Company Monitoring Page for MannKind

latest headlines for company on cafepharma

MannKind Evenly Poised
Yahoo/Zacks
Sat, 09/11/10 - 11:37 am
Tags:
MannKind, investors
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
Tags:
FDA, Questcor Pharmaceuticals, Savient, Alkermes, Arena Pharmaceuticals, Roche, Novartis, Hospira, Human Genome, Alexza, Jazz Pharmaceuticals, Biodel, Amylin, Eli Lilly, Vivus, Avanir, Cadence Pharmaceuticals, Amgen, Cumberland, Orexigen, MannKind, Bristol-Myers Squibb
These Are the Top 10 Pharma Underperform Calls
Motley Fool
Thu, 08/26/10 - 08:03 pm
Tags:
Dendreon, Human Genome, Targacept, Vanda, Pharmacyclics, Acorda Therapeutics, MannKind
Which biotechs are the least efficient?
Fierce Biotech
Fri, 08/20/10 - 12:53 pm
Tags:
MannKind, Orexigen, Aastrom, Hemispherx, Cell Therapeutics
Mannkind falls on securities offering
Marketwatch
Tue, 08/17/10 - 12:07 pm
Tags:
MannKind, stock offering
MannKind / Seaside 88: Not Good News for Investors
Seeking Alpha
Thu, 08/12/10 - 11:33 am
Tags:
MannKind, diabetes, Afrezza, Seaside 88, financing
Technically, MannKind Is a Buy
Motley Fool
Wed, 08/11/10 - 11:03 am
Tags:
diabetes, inhaled insulin, MannKind, Afrezza
MannKind 2Q loss narrows on lower costs
Yahoo/AP
Mon, 08/2/10 - 10:30 am
Tags:
MannKind, earnings
Will MannKind's Afrezza Succeed Where Pfizer's Exubera Failed?
Seeking Alpha
Mon, 07/26/10 - 11:13 am
Tags:
Pfizer, MannKind, Afrezza, diabetes, inhaled insulin
Good News for MannKind
Yahoo/Zacks
Sat, 07/24/10 - 03:05 pm
Tags:
Afrezza, MannKind, inhaled insulin, diabetes
Biotech Stock Mailbag: Exact Sciences
TheStreet.com
Fri, 07/23/10 - 07:16 am
Tags:
EXACT Sciences, MannKind, Gilead Sciences, Somaxon, JNJ, Allos, Cell Therapeutics
What’s Up with MannKind?
Barron's
Wed, 07/14/10 - 04:32 pm
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
Mannkind: Rodman & Renshaw Reiterates Buy on Afrezza Data
Barron's
Thu, 07/1/10 - 08:41 am
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
Diabetes Drug Development Pops and Drops
Motley Fool
Wed, 06/30/10 - 09:57 am
Tags:
diabetes, Orexigen, Contrave, Avandia, GSK, Merck, Eli Lilly, Amylin, Novo Nordisk, JNJ, MannKind, Afrezza
Mannkind Falls Following Afrezza Presentation; Hapoalim Reiterates Sell
Barron's
Mon, 06/28/10 - 02:53 pm
Tags:
MannKind, Afrezza, diabetes, inhaled insulin, Hapoalim
AFREZZA Suppresses Endogenous Glucose Production More Rapidly Than Currently Available Insulin Therapy
Yahoo/BusinessWire
Sun, 06/27/10 - 10:52 am
Tags:
Afrezza, MannKind, diabetes, type 2 diabetes
Diabetes drug makers gain ahead of conference
MarketWatch
Sat, 06/26/10 - 09:13 am
Tags:
Arca pharmaceutical index, MannKind, Amylin, Molecular Insight, diabetes
MannKind Bear Analysts Strike Again
Seeking Alpha
Wed, 06/16/10 - 08:23 am
Tags:
MannKind, Afrezza, Eli Lilly, inhaled insulin, diabetes
Another Step Back For MannKind?
Pharmalot
Fri, 06/11/10 - 10:18 am
Tags:
MannKind, inhaled insulin, diabetes, Afrezza
MannKind Jumps as Inhaled Insulin Shows Superior Data
Barron's
Thu, 06/10/10 - 01:00 pm
Tags:
MannKind, inhaled insulin, Afrezza, diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.